Baird Initiates Coverage On Immunovant with Outperform Rating

Baird initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating.

Benzinga · 01/08/2020 14:40

Baird initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating.